A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
See also reference (FX) in Slovak
faktor nekrotizujúci nádory, alfa
See also reference (FX) in English
Tumor Necrosis Factor-alpha
Links
(14) - ARTICLES
(2) - MeSH descriptor
(3) - CiBaMed
subject heading
openseadragon
Number of the records: 1
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
